File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1038/cgt.2015.9
- Scopus: eid_2-s2.0-84928633192
- PMID: 25721206
- WOS: WOS:000353074400006
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Novel lentiviral-inducible transgene expression systems and versatile single-plasmid reporters for in vitro and in vivo cancer biology studies
Title | Novel lentiviral-inducible transgene expression systems and versatile single-plasmid reporters for in vitro and in vivo cancer biology studies |
---|---|
Authors | |
Issue Date | 2015 |
Publisher | Nature Publishing Group. The Journal's web site is located at http://www.nature.com/cgt |
Citation | Cancer Gene Therapy, 2015, v. 22 n. 4, p. 207-214 How to Cite? |
Abstract | Many of the cancer cell lines derived from solid tumors are difficult to transfect using commonly established transfection approaches. This hurdle for some DNA transfection systems has hindered cancer biology studies. Moreover, there are limited tools for studying pathway activities. Therefore, highly efficient improved gene transfer and versatile genetic tools are required. In this study, we established and developed a comprehensive set of new lentiviral tools to study gene functions and pathway activities. Using the optimized conditions, cancer cell lines achieved >90% transduction efficiency. Novel lentiviral doxycycline-regulated pTet-IRES-EGFP (pTIE) systems for transgene expression and TRE reporters used for pathway activity determination were developed and tested. The pTIE Tet-Off system showed in vitro doxycycline-sensitive responses with low or undetectable leakage of protein expression and in vivo tumor suppression as illustrated using candidate tumor suppressors, Fibulin-2 and THY1. In contrast, the Tet-On system showed dose-dependent responses. The pTRE-EGFP (pTE) and pTRE-FLuc-EF1α-RLuc (pT-FER) reporters with the NFκB p65 subunit consensus sequence showed GFP and firefly luciferase responses, which were directly correlated with TNFα stimulation, respectively. Taken together, these newly developed lentiviral systems provide versatile in vitro and in vivo platforms to strengthen our capabilities for cancer biology studies. |
Persistent Identifier | http://hdl.handle.net/10722/210718 |
ISSN | 2023 Impact Factor: 4.8 2023 SCImago Journal Rankings: 1.457 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shuen, WH | - |
dc.contributor.author | Kan, R | - |
dc.contributor.author | Yu, Z | - |
dc.contributor.author | Lung, HL | - |
dc.contributor.author | Lung, ML | - |
dc.date.accessioned | 2015-06-23T05:48:19Z | - |
dc.date.available | 2015-06-23T05:48:19Z | - |
dc.date.issued | 2015 | - |
dc.identifier.citation | Cancer Gene Therapy, 2015, v. 22 n. 4, p. 207-214 | - |
dc.identifier.issn | 0929-1903 | - |
dc.identifier.uri | http://hdl.handle.net/10722/210718 | - |
dc.description.abstract | Many of the cancer cell lines derived from solid tumors are difficult to transfect using commonly established transfection approaches. This hurdle for some DNA transfection systems has hindered cancer biology studies. Moreover, there are limited tools for studying pathway activities. Therefore, highly efficient improved gene transfer and versatile genetic tools are required. In this study, we established and developed a comprehensive set of new lentiviral tools to study gene functions and pathway activities. Using the optimized conditions, cancer cell lines achieved >90% transduction efficiency. Novel lentiviral doxycycline-regulated pTet-IRES-EGFP (pTIE) systems for transgene expression and TRE reporters used for pathway activity determination were developed and tested. The pTIE Tet-Off system showed in vitro doxycycline-sensitive responses with low or undetectable leakage of protein expression and in vivo tumor suppression as illustrated using candidate tumor suppressors, Fibulin-2 and THY1. In contrast, the Tet-On system showed dose-dependent responses. The pTRE-EGFP (pTE) and pTRE-FLuc-EF1α-RLuc (pT-FER) reporters with the NFκB p65 subunit consensus sequence showed GFP and firefly luciferase responses, which were directly correlated with TNFα stimulation, respectively. Taken together, these newly developed lentiviral systems provide versatile in vitro and in vivo platforms to strengthen our capabilities for cancer biology studies. | - |
dc.language | eng | - |
dc.publisher | Nature Publishing Group. The Journal's web site is located at http://www.nature.com/cgt | - |
dc.relation.ispartof | Cancer Gene Therapy | - |
dc.title | Novel lentiviral-inducible transgene expression systems and versatile single-plasmid reporters for in vitro and in vivo cancer biology studies | - |
dc.type | Article | - |
dc.identifier.email | Yu, Z: zvyu@hku.hk | - |
dc.identifier.email | Lung, HL: hllung2@hku.hk | - |
dc.identifier.email | Lung, ML: mlilung@hku.hk | - |
dc.identifier.authority | Yu, Z=rp02756 | - |
dc.identifier.authority | Lung, HL=rp00299 | - |
dc.identifier.authority | Lung, ML=rp00300 | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1038/cgt.2015.9 | - |
dc.identifier.pmid | 25721206 | - |
dc.identifier.scopus | eid_2-s2.0-84928633192 | - |
dc.identifier.hkuros | 244141 | - |
dc.identifier.volume | 22 | - |
dc.identifier.issue | 4 | - |
dc.identifier.spage | 207 | - |
dc.identifier.epage | 214 | - |
dc.identifier.isi | WOS:000353074400006 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 0929-1903 | - |